Exact Mass: 459.0671

Exact Mass Matches: 459.0671

Found 77 metabolites which its exact mass value is equals to given mass value 459.0671, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate

2-[3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)


   

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 6-sulfate

2-[3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)


   
   

8-oxo-GDP

8-oxo-GDP

C10H15N5O12P2 (459.0192)


A purine ribonucleoside 5-diphosphate that is the 8-oxo derivative of GDP.

   

4-Methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-glucopyranoside

N-{4,5-dihydroxy-2-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]-6-[(sulphooxy)methyl]oxan-3-yl}ethanimidic acid

C18H21NO11S (459.0835)


   

Analogue A

5-Chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboximidate

C23H23Cl2N3O3 (459.1116)


   

Mivebresib

N-[4-(2,4-difluorophenoxy)-3-{6-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}phenyl]ethane-1-sulfonamide

C22H19F2N3O4S (459.1064)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

   

adenylo-succinate

2-[(9-{3,4-dihydroxy-5-[(phosphonatooxy)methyl]oxolan-2-yl}-9H-purin-6-yl)amino]butanedioic acid

C14H14N5O11P (459.0427)


Adenylo-succinate is also known as adenylo-succinic acid. Adenylo-succinate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adenylo-succinate can be found in a number of food items such as broad bean, black huckleberry, chinese broccoli, and pitanga, which makes adenylo-succinate a potential biomarker for the consumption of these food products.

   
   

Antibiotic MI 178-34F18A1

Antibiotic MI 178-34F18A1

C19H19Cl2NO8 (459.0488)


   
   

Lamellarin A4

Lamellarin A4

C25H17NO8 (459.0954)


   

terbium acetylacetonate

terbium acetylacetonate

C15H24O6Tb (459.0826)


   

Benzyl N-N-phenylmethoxycarbonyl-N

Benzyl N-N-phenylmethoxycarbonyl-N

C18H16F3N3O6S (459.0712)


   

(2E,5E)-3-benzyl-2-(4-methoxy phenylimino)-5-(3-methylbenzo[d]thiazol-2(3H)-ylidene)thiazolidin-4-one

(2E,5E)-3-benzyl-2-(4-methoxy phenylimino)-5-(3-methylbenzo[d]thiazol-2(3H)-ylidene)thiazolidin-4-one

C25H21N3O2S2 (459.1075)


   
   

Flurazepam hydrochloride

Flurazepam dihydrochloride

C21H25Cl3FN3O (459.1047)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

8-hydroxy-7-[(4-sulpho-1-naphthyl)azo]quinoline-5-sulphonic acid

8-hydroxy-7-[(4-sulpho-1-naphthyl)azo]quinoline-5-sulphonic acid

C19H13N3O7S2 (459.0195)


   

Aluminum triquinolin-8-olate

Aluminum triquinolin-8-olate

C27H18AlN3O3 (459.1164)


   

Ticolubant

Ticolubant

C23H19Cl2NO3S (459.0463)


C308 - Immunotherapeutic Agent

   

8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid

8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid

C19H13N3O7S2 (459.0195)


   

4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide

4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide

C25H21N3O2S2 (459.1075)


   

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-5-oxo-6-thiazolo[3,2-a]pyrimidinecarboxamide

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-5-oxo-6-thiazolo[3,2-a]pyrimidinecarboxamide

C19H17N5O5S2 (459.0671)


   

Prinomastat hydrochloride

Prinomastat hydrochloride

C18H22ClN3O5S2 (459.0689)


   

7n-Methyl-8-hydroguanosine-5-diphosphate

7n-Methyl-8-hydroguanosine-5-diphosphate

C11H19N5O11P2 (459.0556)


   

(C8-R)-Hydantocidin 5-phosphate

(C8-R)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)


   

(C8-S)-Hydantocidin 5-phosphate

(C8-S)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)


   

Mivebresib

Mivebresib

C22H19F2N3O4S (459.1064)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

   
   

N(6)-(1,2-dicarboxyethyl)-AMP

N(6)-(1,2-dicarboxyethyl)-AMP

C14H14N5O11P-4 (459.0427)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

wogonin 7-O-beta-D-glucuronate

wogonin 7-O-beta-D-glucuronate

C22H19O11- (459.0927)


The monocarboxylic acid anion that is the conjugate base of wogonin 7-O-beta-D-glucuronide.

   

CDP-N-methylethanolamine(1-)

CDP-N-methylethanolamine(1-)

C12H21N4O11P2- (459.0682)


   

oroxylin A 7-O-beta-D-glucuronate

oroxylin A 7-O-beta-D-glucuronate

C22H19O11- (459.0927)


The monocarboxylic acid anion that is the conjugate base of oroxylin A 7-O-beta-D-glucuronide.

   

5-O-[N-(L-Aspartyl)sulfamoyl]adenosine

5-O-[N-(L-Aspartyl)sulfamoyl]adenosine

C14H17N7O9S-2 (459.0808)


   

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc

C14H21NO14S (459.0683)


   

Aspartyl-phosphonate-adenosine

Aspartyl-phosphonate-adenosine

C15H20N6O9P- (459.1029)


   

(2R,3R,4S)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4S)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)


   

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)


   

5-chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide

5-chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide

C23H23Cl2N3O3 (459.1116)


   

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(methylazaniumyl)ethyl phosphate

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(methylazaniumyl)ethyl phosphate

C12H21N4O11P2- (459.0682)


   

4-(2,6-Difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine

4-(2,6-Difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine

C19H19F2NO6S2 (459.0622)


   

(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H19N4O5S2+ (459.0797)


   

5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide

5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide

C22H16Cl2FN3O3 (459.0553)


   

N-[1-[[anilino(sulfanylidene)methyl]amino]-2,2,2-trichloroethyl]-2-(4-ethylphenoxy)acetamide

N-[1-[[anilino(sulfanylidene)methyl]amino]-2,2,2-trichloroethyl]-2-(4-ethylphenoxy)acetamide

C19H20Cl3N3O2S (459.0342)


   

(2E)-3-[5-(4-bromophenyl)furan-2-yl]-2-cyano-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide

(2E)-3-[5-(4-bromophenyl)furan-2-yl]-2-cyano-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide

C24H18BrN3O2 (459.0582)


   

4-[(2-Methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester

4-[(2-Methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester

C21H21N3O7S (459.11)


   

5-chloro-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-2-benzofurancarboxamide

5-chloro-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-2-benzofurancarboxamide

C21H18ClN3O5S (459.0656)


   

1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(2-bromophenyl)methylidene]-5-(pyrrolidin-1-ylmethyl)-1H-1,2,3-triazole-4-carbohydrazide

1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(2-bromophenyl)methylidene]-5-(pyrrolidin-1-ylmethyl)-1H-1,2,3-triazole-4-carbohydrazide

C17H18BrN9O2 (459.0767)


   

prunetin-5-O-beta-D-glucuronide

prunetin-5-O-beta-D-glucuronide

C22H19O11- (459.0927)


   

prunetin-4-O-beta-D-glucuronide

prunetin-4-O-beta-D-glucuronide

C22H19O11- (459.0927)


   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S

C14H21NO14S (459.0683)


   

(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6S,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)


   

Farnesyl triphosphate(3-)

Farnesyl triphosphate(3-)

C15H26O10P3-3 (459.0739)


   

2-(Acetylamino)-2-Deoxy-3-O-(4-Deoxy-Alpha-L-Threo-Hex-4-Enopyranuronosyl)-4-O-Sulfo-Beta-D-Galactopyranose

2-(Acetylamino)-2-Deoxy-3-O-(4-Deoxy-Alpha-L-Threo-Hex-4-Enopyranuronosyl)-4-O-Sulfo-Beta-D-Galactopyranose

C14H21NO14S (459.0683)


   

[5-(2-Amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methylperoxy phosphono hydrogen phosphate

[5-(2-Amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methylperoxy phosphono hydrogen phosphate

C10H15N5O12P2 (459.0192)


   

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactopyranose

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)


   

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-6-O-sulfo-D-galactopyranose

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-6-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)


   

7-methyl-7,8-dihydroguanosine-5-diphosphate

7-methyl-7,8-dihydroguanosine-5-diphosphate

C11H19N5O11P2 (459.0556)


A purine ribonucleoside 5-diphosphate having 7-methyl-7,8-dihydroguanine as the nucleobase.

   

N(6)-(1,2-dicarboxylatoethyl)-AMP(4-)

N(6)-(1,2-dicarboxylatoethyl)-AMP(4-)

C14H14N5O11P (459.0427)


Tetraanion of N(6)-(1,2-dicarboxyethyl)-AMP arising from deprotonation of carboxylic acid and phosphate functions.

   

KG5

KG5

C20H16F3N7OS (459.1089)


KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor. KG5 also inhibits Flt3, KIT and c-Raf. KG5 has anticancer, antiangiogenic activities[1].

   

(4r,5s,6r)-4,5-dihydroxy-6-[(s)-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

(4r,5s,6r)-4,5-dihydroxy-6-[(s)-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)


   

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-5,7,9,12,14,16,18,20-octaen-3-one

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-5,7,9,12,14,16,18,20-octaen-3-one

C25H17NO8 (459.0954)


   

2,8-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

2,8-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)


   

(4s,5s,6s)-4,5-dihydroxy-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

(4s,5s,6s)-4,5-dihydroxy-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)


   

2,6-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one

2,6-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)


   

8-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

8-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C20H17N3O8S (459.0736)


   

8-{[(2s)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

8-{[(2s)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-hydroxy-6-(methoxycarbonyl)phenazine-1-carboxylic acid

C20H17N3O8S (459.0736)


   

2,6-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one

2,6-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)


   

(2r,3s,5s,6s)-6-{[(3s,3ar)-7-chloro-5-(cyanomethyl)-3-hydroxy-3h-cyclopenta[a]inden-3a-yl]oxy}-5-hydroxy-2,3-dimethyl-4-oxooxan-3-yl acetate

(2r,3s,5s,6s)-6-{[(3s,3ar)-7-chloro-5-(cyanomethyl)-3-hydroxy-3h-cyclopenta[a]inden-3a-yl]oxy}-5-hydroxy-2,3-dimethyl-4-oxooxan-3-yl acetate

C23H22ClNO7 (459.1085)


   

2,8-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

2,8-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)